Tompong, Mary Jean .
HRN: 21-51-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2022
CEFUROXIME 1.5GM (VIAL)
06/30/2022
07/07/2022
IVTT
1.5g
Q8hrs
S/P LTCS MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes